Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

Cancer Letters

Volumn 340, Issue 2, 2013, Pages 152-160

  Patel, Lalit R ^a,b   Nykter, Matti ^c   Chen, Kexin ^d   Zhang, Wei ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bioinformatics; Cancer genomics; Chromosomal conformation sequencing; Next generation sequencing; Transcriptomics; Tumor heterogeneity

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TRANSCRIPTOME;

ARTIFICIAL CHROMOSOME; CANCER GENETICS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER RESISTANCE; CARCINOGENESIS; CHROMATIN STRUCTURE; COLORECTAL CARCINOMA; CONFORMATION; DEVELOPMENTAL BIOLOGY; DNA METHYLATION; EPIGENETICS; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MALIGNANT TRANSFORMATION; MATHEMATICAL COMPUTING; MELANOMA; MOLECULAR EVOLUTION; MOLECULAR GENETICS; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RNA PROCESSING; RNA SEQUENCE; SHORT SURVEY; SOMATIC MUTATION; TRANSCRIPTOMICS;

EID: 84887613659     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.10.018     Document Type: Review

References (69)

1. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33:49-54.
2. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 2000, 24:227-235.
3. Garnett M.J., Edelman E.J., Heidorn S.J., Greenman C.D., Dastur A., Lau K.W., Greninger P., Thompson I.R., Luo X., Soares J., Liu Q., Iorio F., Surdez D., Chen L., Milano R.J., Bignell G.R., Tam A.T., Davies H., Stevenson J.A., Barthorpe S., Lutz S.R., Kogera F., Lawrence K., McLaren-Douglas A., Mitropoulos X., Mironenko T., Thi H., Richardson L., Zhou W., Jewitt F., Zhang T., O'Brien P., Boisvert J.L., Price S., Hur W., Yang W., Deng X., Butler A., Choi H.G., Chang J.W., Baselga J., Stamenkovic I., Engelman J.A., Sharma S.V., Delattre O., Saez-Rodriguez J., Gray N.S., Settleman J., Futreal P.A., Haber D.A., Stratton M.R., Ramaswamy S., McDermott U., Benes C.H. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012, 483:570-575.
4. Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012, 483:603-607.
5. Davies J.J., Wilson I.M., Lam W.L. Array CGH technologies and their applications to cancer genomes. Chromosome Res. 2005, 13:237-248.
6. Dutt A., Beroukhim R. Single nucleotide polymorphism array analysis of cancer. Curr. Opin. Oncol. 2007, 19:43-49.
7. Schulze A., Downward J. Navigating gene expression using microarrays - a technology review. Nat. Cell Biol. 2001, 3:E190-E195.
8. Metzker M.L. Applications of next-generation sequencing: sequencing technologies - the next generation. Nat. Rev. Genet. 2010, 11:31-46.
9. Collins F.S., Barker A.D. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci. Am. 2007, 296:50-57.
10. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., Nik-Zainal S., Martin S., Varela I., Bignell G.R., Yates L.R., Papaemmanuil E., Beare D., Butler A., Cheverton A., Gamble J., Hinton J., Jia M., Jayakumar A., Jones D., Latimer C., Lau K.W., McLaren S., McBride D.J., Menzies A., Mudie L., Raine K., Rad R., Chapman M.S., Teague J., Easton D., Langerod A., Lee M.T., Shen C.Y., Tee B.T., Huimin B.W., Broeks A., Vargas A.C., Turashvili G., Martens J., Fatima A., Miron P., Chin S.F., Thomas G., Boyault S., Mariani O., Lakhani S.R., van de Vijver M., van 't Veer L., Foekens J., Desmedt C., Sotiriou C., Tutt A., Caldas C., Reis-Filho J.S., Aparicio S.A., Salomon A.V., Borresen-Dale A.L., Richardson A.L., Campbell P.J., Futreal P.A., Stratton M.R. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404.
11. Barbieri C.E., Baca S.C., Lawrence M.S., Demichelis F., Blattner M., Theurillat J.P., White T.A., Stojanov P., Van Allen E., Stransky N., Nickerson E., Chae S.S., Boysen G., Auclair D., Onofrio R.C., Park K., Kitabayashi N., Macdonald T.Y., Sheikh K., Vuong T., Guiducci C., Cibulskis K., Sivachenko A., Carter S.L., Saksena G., Voet D., Hussain W.M., Ramos A.H., Winckler W., Redman M.C., Ardlie K., Tewari A.K., Mosquera J.M., Rupp N., Wild P.J., Moch H., Morrissey C., Nelson P.S., Kantoff P.W., Gabriel S.B., Golub T.R., Meyerson M., Lander E.S., Getz G., Rubin M.A., Garraway L.A. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 2012, 44:685-689.
12. Wei X.M., Walia V., Lin J.C., Teer J.K., Prickett T.D., Gartner J., Davis S., Stemke-Hale K., Davies M.A., Gershenwald J.E., Robinson W., Robinson S., Rosenberg S.A., Samuels Y., Progra N.C.S. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat. Genet. 2011, 43:442-446.
13. Ellis M.J., Ding L., Shen D., Luo J.Q., Suman V.J., Wallis J.W., Van Tine B.A., Hoog J., Goiffon R.J., Goldstein T.C., Ng S., Lin L., Crowder R., Snider J., Ballman K., Weber J., Chen K., Koboldt D.C., Kandoth C., Schierding W.S., McMichael J.F., Miller C.A., Lu C., Harris C.C., McLellan M.D., Wendl M.C., DeSchryver K., Allred D.C., Esserman L., Unzeitig G., Margenthaler J., Babiera G.V., Marcom P.K., Guenther J.M., Leitch M., Hunt K., Olson J., Tao Y., Maher C.A., Fulton L.L., Fulton R.S., Harrison M., Oberkfell B., Du F.Y., Demeter R., Vickery T.L., Elhammali A., Piwnica-Worms H., McDonald S., Watson M., Dooling D.J., Ota D., Chang L.W., Bose R., Ley T.J., Piwnica-Worms D., Stuart J.M., Wilson R.K., Mardis E.R. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360.
14. Berger M.F., Lawrence M.S., Demichelis F., Drier Y., Cibulskis K., Sivachenko A.Y., Sboner A., Esgueva R., Pflueger D., Sougnez C., Onofrio R., Carter S.L., Park K., Habegger L., Ambrogio L., Fennell T., Parkin M., Saksena G., Voet D., Ramos A.H., Pugh T.J., Wilkinson J., Fisher S., Winckler W., Mahan S., Ardlie K., Baldwin J., Simons J.W., Kitabayashi N., MacDonald T.Y., Kantoff P.W., Chin L., Gabriel S.B., Gerstein M.B., Golub T.R., Meyerson M., Tewari A., Lander E.S., Getz G., Rubin M.A., Garraway L.A. The genomic complexity of primary human prostate cancer. Nature 2011, 470:214-220.
15. Adams J. Complex genomes: shotgun sequencing. Nat. Educ. 2008, 1.
16. Weber J.L., Myers E.W. Human whole-genome shotgun sequencing. Genome Res. 1997, 7:401-409.
17. Green P. Against a whole-genome shotgun. Genome Res. 1997, 7:410-417.
18. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R., Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K., Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D., McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M., Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C., Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B., Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J., Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E., Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X. The sequence of the human genome. Science 2001, 291:1304-1351.
19. K.A. Wetterstrand, DNA sequencing costs: data from the NHGRI Large-Scale Genome Sequencing Program www.genome.gov/sequencingcosts. (accessed August 2012).
20. Curtin J.A., Fridlyand J., Kageshita T., Patel H.N., Busam K.J., Kutzner H., Cho K.H., Aiba S., Brocker E.B., LeBoit P.E., Pinkel D., Bastian B.C. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 2005, 353:2135-2147.
21. Bell D., Berchuck A., Birrer M., Chien J., Cramer D.W., Dao F., Dhir R., DiSaia P., Gabra H., Glenn P., Godwin A.K., Gross J., Hartmann L., Huang M., Huntsman D.G., Iacocca M., Imielinski M., Kalloger S., Karlan B.Y., Levine D.A., Mills G.B., Morrison C., Mutch D., Olvera N., Orsulic S., Park K., Petrelli N., Rabeno B., Rader J.S., Sikic B.I., Smith-McCune K., Sood A.K., Bowtell D., Penny R., Testa J.R., Chang K., Dinh H.H., Drummond J.A., Fowler G., Gunaratne P., Hawes A.C., Kovar C.L., Lewis L.R., Morgan M.B., Newsham I.F., Santibanez J., Reid J.G., Trevino L.R., Wu Y.Q., Wang M., Muzny D.M., Wheeler D.A., Gibbs R.A., Getz G., Lawrence M.S., Cibulskis K., Sivachenko A.Y., Sougnez C., Voet D., Wilkinson J., Bloom T., Ardlie K., Fennell T., Baldwin J., Gabriel S., Lander E.S., Ding L., Fulton R.S., Koboldt D.C., McLellan M.D., Wylie T., Walker J., O'Laughlin M., Dooling D.J., Fulton L., Abbott R., Dees N.D., Zhang Q., Kandoth C., Wendl M., Schierding W., Shen D., Harris C.C., Schmidt H., Kalicki J., Delehaunty K.D., Fronick C.C., Demeter R., Cook L., Wallis J.W., Lin L., Magrini V.J., Hodges J.S., Eldred J.M., Smith S.M., Pohl C.S., Vandin F., Raphael B.J., Weinstock G.M., Mardis R., Wilson R.K., Meyerson M., Winckler W., Getz G., Verhaak R.G.W., Carter S.L., Mermel C.H., Saksena G., Nguyen H., Onofrio R.C., Lawrence M.S., Hubbard D., Gupta S., Crenshaw A., Ramos A.H., Ardlie K., Chin L., Protopopov A., Zhang J.H., Kim T.M., Perna I., Xiao Y., Zhang H., Ren G., Sathiamoorthy N., Park R.W., Lee E., Park P.J., Kucherlapati R., Absher D.M., Waite L., Sherlock G., Brooks J.D., Li J.Z., Xu J., Myers R.M., Laird P.W., Cope L., Herman J.G., Shen H., Weisenberger D.J., Noushmehr H., Pan F., Triche T., Berman B.P., Van den Berg D.J., Buckley J., Baylin S.B., Spellman P.T., Purdom E., Neuvial P., Bengtsson H., Jakkula L.R., Durinck S., Han J., Dorton S., Marr H., Choi Y.G., Wang V., Wang N.J., Ngai J., Conboy J.G., Parvin B., Feiler H.S., Speed T.P., Gray J.W., Levine D.A., Socci N.D., Liang Y., Taylor B.S., Schultz N., Borsu L., Lash A.E., Brennan C., Viale A., Sander C., Ladanyi M., Hoadley K.A., Meng S., Du Y., Shi Y., Li L., Turman Y.J., Zang D., Helms E.B., Balu S., Zhou X., Wu J., Topal M.D., Hayes D.N., Perou C.M., Getz G., Voet D., Saksena G., Zhang J.N.H., Zhang H., Wu C.J., Shukla S., Cibulskis K., Lawrence M.S., Sivachenko A., Jing R., Park R.W., Liu Y., Park P.J., Noble M., Chin L., Carter H., Kim D., Karchin R., Spellman P.T., Purdom E., Neuvial P., Bengtsson H., Durinck S., Han J., Korkola J.E., Heiser L.M., Cho R.J., Hu Z., Parvin B., Speed T.P., Gray J.W., Schultz N., Cerami E., Taylor B.S., Olshen A., Reva B., Antipin Y., Shen R., Mankoo P., Sheridan R., Ciriello G., Chang W.K., Bernanke J.A., Borsu L., Levine D.A., Ladanyi M., Sander C., Haussler D., Benz C.C., Stuart J.M., Benz S.C., Sanborn J.Z., Vaske C.J., Zhu J., Szeto C., Scott G.K., Yau C., Hoadley K.A., Du Y., Balu S., Hayes D.N., Perou C.M., Wilkerson M.D., Zhang N., Akbani R., Baggerly K.A., Yung W.K., Mills G.B., Weinstein J.N., Penny R., Shelton T., Grimm D., Hatfield M., Morris S., Yena P., Rhodes P., Sherman M., Paulauskis J., Millis S., Kahn A., Greene J.M., Sfeir R., Jensen M.A., Chen J., Whitmore J., Alonso S., Jordan J., Chu A., Zhang J.H., Barker A., Compton C., Eley G., Ferguson M., Fielding P., Gerhard D.S., Myles R., Schaefer C., Shaw K.R.M., Vaught J., Vockley J.B., Good P.J., Guyer M.S., Ozenberger B., Peterson J., Thomson E., Network C.G.A.R. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.
22. Muzny D.M., Bainbridge M.N., Chang K., Dinh H.H., Drummond J.A., Fowler G., Kovar C.L., Lewis L.R., Morgan M.B., Newsham I.F., Reid J.G., Santibanez J., Shinbrot E., Trevino L.R., Wu Y.Q., Wang M., Gunaratne P., Donehower L.A., Creighton C.J., Wheeler D.A., Gibbs R.A., Lawrence M.S., Voet D., Jing R., Cibulskis K., Sivachenko A., Stojanov P., McKenna A., Lander E.S., Gabriel S., Getz G., Ding L., Fulton R.S., Koboldt D.C., Wylie T., Walker J., Dooling D.J., Fulton L., Delehaunty K.D., Fronick C.C., Demeter R., Mardis E.R., Wilson R.K., Chu A., Chun H.J.E., Mungall A.J., Pleasance E., Robertson A.G., Stoll D., Balasundaram M., Birol I., Butterfield Y.S.N., Chuah E., Coope R.J.N., Dhalla N., Guin R., Hirst C., Hirst M., Holt R.A., Lee D., Li H.I., Mayo M., Moore R.A., Schein J.E., Slobodan J.R., Tam A., Thiessen N., Varhol R., Zeng T., Zhao Y., Jones S.J.M., Marra M.A., Bass A.J., Ramos A.H., Saksena G., Cherniack A.D., Schumacher S.E., Tabak B., Carter S.L., Pho N.H., Nguyen H., Onofrio R.C., Crenshaw A., Ardlie K., Beroukhim R., Winckler W., Getz G., Meyerson M., Protopopov A., Zhang J., Hadjipanayis A., Lee E., Xi R., Yang L., Ren X., Zhang H., Sathiamoorthy N., Shukla S., Chen P.C., Haseley P., Xiao Y., Lee S., Seidman J., Chin L., Park P.J., Kucherlapati R., Auman J.T., Hoadley K.A., Du Y., Wilkerson M.D., Shi Y., Liquori C., Meng S., Li L., Turman Y.J., Topal M.D., Tan D., Waring S., Buda E., Walsh J., Jones C.D., Mieczkowski P.A., Singh D., Wu J., Gulabani A., Dolina P., Bodenheimer T., Hoyle A.P., Simons J.V., Soloway M., Mose L.E., Jefferys S.R., Balu S., O'Connor B.D., Prins J.F., Chiang D.Y., Hayes D.N., Perou C.M., Hinoue T., Weisenberger D.J., Maglinte D.T., Pan F., Berman B.P., Van den Berg D.J., Shen H., Jr T.T., Baylin S.B., Laird P.W., Getz G., Noble M., Voet D., Saksena G., Gehlenborg N., DiCara D., Zhang J., Zhang H., Wu C.J., Liu S.Y., Shukla S., Lawrence M.S., Zhou L., Sivachenko A., Lin P., Stojanov P., Jing R., Park R.W., Nazaire M.D., Robinson J., Thorvaldsdottir H., Mesirov J., Park P.J., Chin L., Thorsson V., Reynolds S.M., Bernard B., Kreisberg R., Lin J., Iype L., Bressler R., Erkkila T., Gundapuneni M., Liu Y., Norberg A., Robinson T., Yang D., Zhang W., Shmulevich I., De Ronde J.J., Schultz N., Cerami E., Ciriello G., Goldberg A.P., Gross B., Jacobsen A., Gao J., Kaczkowski B., Sinha R., Aksoy B.A., Antipin Y., Reva B., Shen R., Taylor B.S., Chan T.A., Ladanyi M., Sander C., Akbani R., Zhang N., Broom B.M., Casasent T., Unruh A., Wakefield C., Hamilton S.R., Cason R.C., Baggerly K.A., Weinstein J.N., Haussler D., Benz C.C., Stuart J.M., Benz S.C., Sanborn J.Z., Vaske C.J., Zhu J., Szeto C., Scott G.K., Yau C., Ng S., Goldstein T., Ellrott K., Collisson E., Cozen A.E., Zerbino D., Wilks C., Craft B., Spellman P., Penny R., Shelton T., Hatfield M., Morris S., Yena P., Shelton C., Sherman M., Paulauskis J., Gastier-Foster J.M., Bowen J., Ramirez N.C., Black A., Pyatt R., Wise L., White P., Bertagnolli M., Brown J., Chan T.A., Chu G.C., Czerwinski C., Denstman F., Dhir R., Doerner A., Fuchs C.S., Guillem J.G., Iacocca M., Juhl H., Kaufman A., Kohl B., Van Le X., Mariano M.C., Medina E.N., Meyers M., Nash G.M., Paty P.B., Petrelli N., Rabeno B., Richards W.G., Solit D., Swanson P., Temple L., Tepper J.E., Thorp R., Vakiani E., Weiser M.R., Willis J.E., Witkin G., Zeng Z., Zinner M.J., Zornig C., Jensen M.A., Sfeir R., Kahn A.B., Chu A.L., Kothiyal P., Wang Z., Snyder E.E., Pontius J., Pihl T.D., Ayala B., Backus M., Walton J., Whitmore J., Baboud J., Berton D.L., Nicholls M.C., Srinivasan D., Raman R., Girshik S., Kigonya P.A., Alonso S., Sanbhadti R.N., Barletta S.P., Greene J.M., Pot D.A., Shaw K.R.M., Dillon L.A.L., Buetow K., Davidsen T., Demchok J.A., Eley G., Ferguson M., Fielding P., Schaefer C., Sheth M., Yang L., Guyer M.S., Ozenberger B.A., Palchik J.D., Peterson J., Sofia H.J., Thomson E. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
23. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., Mc Henry K.T., Pinchback R.M., Ligon A.H., Cho Y.J., Haery L., Greulich H., Reich M., Winckler W., Lawrence M.S., Weir B.A., Tanaka K.E., Chiang D.Y., Bass A.J., Loo A., Hoffman C., Prensner J., Liefeld T., Gao Q., Yecies D., Signoretti S., Maher E., Kaye F.J., Sasaki H., Tepper J.E., Fletcher J.A., Tabernero J., Baselga J., Tsao M.S., Demichelis F., Rubin M.A., Janne P.A., Daly M.J., Nucera C., Levine R.L., Ebert B.L., Gabriel S., Rustgi A.K., Antonescu C.R., Ladanyi M., Letai A., Garraway L.A., Loda M., Beer D.G., True L.D., Okamoto A., Pomeroy S.L., Singer S., Golub T.R., Lander E.S., Getz G., Sellers W.R., Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
24. Campbell P.J., Yachida S., Mudie L.J., Stephens P.J., Pleasance E.D., Stebbings L.A., Morsberger L.A., Latimer C., McLaren S., Lin M.L., McBride D.J., Varela I., Nik-Zainal S.A., Leroy C., Jia M., Menzies A., Butler A.P., Teague J.W., Griffin C.A., Burton J., Swerdlow H., Quail M.A., Stratton M.R., Iacobuzio-Donahue C., Futreal P.A. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
25. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
26. De S., Michor F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat. Struct. Mol. Biol. 2011, 18:950-955.
27. Fudenberg G., Getz G., Meyerson M., Mirny L.A. High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat. Biotechnol. 2011, 29:1109-1113.
28. Adams M.D., Kelley J.M., Gocayne J.D., Dubnick M., Polymeropoulos M.H., Xiao H., Merril C.R., Wu A., Olde B., Moreno R.F., et al. Complementary DNA sequencing: expressed sequence tags and human genome project. Science 1991, 252:1651-1656.
29. Maher C.A., Kumar-Sinha C., Cao X., Kalyana-Sundaram S., Han B., Jing X., Sam L., Barrette T., Palanisamy N., Chinnaiyan A.M. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458:97-101.
30. Prensner J.R., Iyer M.K., Balbin O.A., Dhanasekaran S.M., Cao Q., Brenner J.C., Laxman B., Asangani I.A., Grasso C.S., Kominsky H.D., Cao X., Jing X., Wang X., Siddiqui J., Wei J.T., Robinson D., Iyer H.K., Palanisamy N., Maher C.A., Chinnaiyan A.M. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 2011, 29:742-749.
31. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28:511-515.
32. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011, 25:1915-1927.
33. Zhang Y., Gong M., Yuan H., Park H.G., Frierson H.F., Li H. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov. 2012, 2:598-607.
34. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
35. Watson P.A., Chen Y.F., Balbas M.D., Wongvipat J., Socci N.D., Viale A., Kim K., Sawyers C.L. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc. Natl. Acad. Sci. USA 2010, 107:16759-16765.
36. Govindan R., Ding L., Griffith M., Subramanian J., Dees N.D., Kanchi K.L., Maher C.A., Fulton R., Fulton L., Wallis J., Chen K., Walker J., McDonald S., Bose R., Ornitz D., Xiong D., You M., Dooling D.J., Watson M., Mardis E.R., Wilson R.K. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012, 150:1121-1134.
37. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002, 3:662-673.
38. Turner B.M. Cellular memory and the histone code. Cell 2002, 111:285-291.
39. Park P.J. ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 2009, 10:669-680.
40. Krueger F., Kreck B., Franke A., Andrews S.R. DNA methylome analysis using short bisulfite sequencing data. Nat. Methods 2012, 9:145-151.
41. Kim J.H., Dhanasekaran S.M., Prensner J.R., Cao X., Robinson D., Kalyana-Sundaram S., Huang C., Shankar S., Jing X., Iyer M., Hu M., Sam L., Grasso C., Maher C.A., Palanisamy N., Mehra R., Kominsky H.D., Siddiqui J., Yu J., Qin Z.S., Chinnaiyan A.M. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res. 2011, 21:1028-1041.
42. L. Song, G.E. Crawford, DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harbor protocols 2010 (2010) pdb prot5384.
43. Akhtar-Zaidi B., Cowper-Sal-lari R., Corradin O., Saiakhova A., Bartels C.F., Balasubramanian D., Myeroff L., Lutterbaugh J., Jarrar A., Kalady M.F., Willis J., Moore J.H., Tesar P.J., Laframboise T., Markowitz S., Lupien M., Scacheri P.C. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012, 336:736-739.
44. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428.
45. Misteli T. Beyond the sequence. cellular organization of genome function. Cell 2007, 128:787-800.
46. Dekker J. Gene regulation in the third dimension. Science 2008, 319:1793-1794.
47. Sexton T., Schober H., Fraser P., Gasser S.M. Gene regulation through nuclear organization. Nat. Struct. Mol. Biol. 2007, 14:1049-1055.
48. Lieberman-Aiden E., van Berkum N.L., Williams L., Imakaev M., Ragoczy T., Telling A., Amit I., Lajoie B.R., Sabo P.J., Dorschner M.O., Sandstrom R., Bernstein B., Bender M.A., Groudine M., Gnirke A., Stamatoyannopoulos J., Mirny L.A., Lander E.S., Dekker J. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
49. Rickman D.S., Soong T.D., Moss B., Mosquera J.M., Dlabal J., Terry S., MacDonald T.Y., Tripodi J., Bunting K., Najfeld V., Demichelis F., Melnick A.M., Elemento O., Rubin M.A. Oncogene-mediated alterations in chromatin conformation. Proc. Natl. Acad. Sci. USA 2012, 109:9083-9088.
50. Li G., Fullwood M.J., Xu H., Mulawadi F.H., Velkov S., Vega V., Ariyaratne P.N., Mohamed Y.B., Ooi H.S., Tennakoon C., Wei C.L., Ruan Y., Sung W.K. ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biol. 2010, 11:R22.
51. Dostie J., Richmond T.A., Arnaout R.A., Selzer R.R., Lee W.L., Honan T.A., Rubio E.D., Krumm A., Lamb J., Nusbaum C., Green R.D., Dekker J. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res. 2006, 16:1299-1309.
52. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
53. Weinstein J.N. Integromic analysis of the NCI-60 cancer cell lines. Breast Dis. 2004, 19:11-22.
54. Shankavaram U.T., Varma S., Kane D., Sunshine M., Chary K.K., Reinhold W.C., Pommier Y., Weinstein J.N. Cell miner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 2009, 10:277.
55. Ciriello G., Cerami E., Sander C., Schultz N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 2012, 22:398-406.
56. Le Cao K.A., Gonzalez I., Dejean S. IntegrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 2009, 25:2855-2856.
57. Yli-Harja O., Ylipaa A., Nykter M., Zhang W. Cancer systems biology: signal processing for cancer research. Chin. J. Cancer 2011, 30:221-225.
58. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., Sulman E.P., Anne S.L., Doetsch F., Colman H., Lasorella A., Aldape K., Califano A., Iavarone A. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463:318-325.
59. Vaske C.J., Benz S.C., Sanborn J.Z., Earl D., Szeto C., Zhu J., Haussler D., Stuart J.M. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 2010, 26:i237-245.
60. Guan Y.F., Li G.R., Wang R.J., Yi Y.T., Yang L., Jiang D., Zhang X.P., Peng Y. Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer. Chin. J. cancer 2012, 31:463-470.
61. Shah N.P., Tran C., Lee F.Y., Chen P., Norris D., Sawyers C.L. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 2004, 305:399-401.
62. Nahta R., Yu D., Hung M.C., Hortobagyi G.N., Esteva F.J. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat. Clin. Pract. Oncol. 2006, 3:269-280.
63. Engelman J.A., Janne P.A. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Clin. Cancer Res. 2008, 14:2895-2899.
64. Villanueva J., Vultur A., Lee J.T., Somasundaram R., Fukunaga-Kalabis M., Cipolla A.K., Wubbenhorst B., Xu X., Gimotty P.A., Kee D., Santiago-Walker A.E., Letrero R., D'Andrea K., Pushparajan A., Hayden J.E., Brown K.D., Laquerre S., McArthur G.A., Sosman J.A., Nathanson K.L., Herlyn M. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell 2010, 18:683-695.
65. Michor F., Iwasa Y., Nowak M.A. Dynamics of cancer progression. Nat. Rev. Cancer 2004, 4:197-205.
66. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., Cook K., Stepansky A., Levy D., Esposito D., Muthuswamy L., Krasnitz A., McCombie W.R., Hicks J., Wigler M. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.
67. Tang F., Barbacioru C., Wang Y., Nordman E., Lee C., Xu N., Wang X., Bodeau J., Tuch B.B., Siddiqui A., Lao K., Surani M.A. MRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 2009, 6:377-382.
68. Tang F., Barbacioru C., Bao S., Lee C., Nordman E., Wang X., Lao K., Surani M.A. Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell 2010, 6:468-478.
69. Ramskold D., Luo S., Wang Y.C., Li R., Deng Q., Faridani O.R., Daniels G.A., Khrebtukova I., Loring J.F., Laurent L.C., Schroth G.P., Sandberg R. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 2012, 30:777-782.